Abstract:Abstract Disclosure: Y. Li: None. T. Cacciottolo: None. I.S. Farooqi: None. Y. Xu: None. The global surge in obesity over recent decades poses formidable challenges to public health and economic well-being. Transient Receptor Potential Channel 5 (TRPC5) emerges as a pivotal membrane-spanning cation channel implicated in energy homeostasis, pain modulation, and fear responses. Here, we identified microdeletions on chromosome Xq23 disrupting TRPC5 in boys with food-seeking, obesity, anxiety and autism. Significantly, these microdeletions were inherited from mothers grappling with a constellation of health issues, including obesity and anxiety, suggesting a potential intergenerational aspect to TRPC5-related conditions. We examined approximately 450,000 individuals with exome sequence data from the UK Biobank and found that the TRPC5 gene is the most strongly associated X-linked gene for human body mass index. Moreover, we identified 7 rare TRPC5 variants in patients with severe obesity underscores the potential role of TRPC5 in shaping the obesity phenotype. Functional experiments with HEK293 cells demonstrated that these variants led to a loss of Trpc5 function. Knock-in male mice harboring a human loss-of-function (LOF) TRPC5 variant developed obesity, anxiety, reduced social exploratory behavior and increased aggression; female mice homozygous for the same variant showed similar deficits with reduced severity. We found approximately 91% proopiomelanocortin (Pomc) neurons in arcuate nucleus of the hypothalamus (ARH) express Trpc5 in wild-type male mice. Utilizing the TRPC5 agonist benzothiadiazide derivative (BTD), we found that BTD (i.p., 10 mg/kg) reduced food intake and increased c-Fos expression in Pomc neurons in wild-type mice compared to the vehicle injection group. Importantly, the activation of Trpc5 using BTD did not induce toxicity or aversive effects. Importantly, chemogenetic inactivation using designer receptor exclusively activated by designer drugs (DREADD) of hM4Di-expressing Pomc neurons with clozapine N-oxide (CNO; i.p., 1 mg/kg) effectively blocked BTD-induced anorexia and c-Fos expression in Pomc neurons. Furthermore, we found that BTD-induced anorexia and c-Fos expression in Pomc neurons were blocked in mice with a LOF TRPC5 variant. This suggesting that the effects of BTD on food intake are mediated through Trpc5 in Pomc neurons. In conclusion, our study provides compelling evidence for the involvement of TRPC5 in the intricate regulation of human appetite, body weight, and maladaptive behaviors. Our findings suggest that melanocortin receptor agonists might be effective in treating severe obesity in individuals carrying TRPC5 variants. We suggest that TRPC5 should be included in diagnostic gene panels for severe childhood-onset obesity. Presentation: 6/1/2024

Genetic and functional analyses of CTBP2 in anorexia nervosa and body weight regulation

Lipocalin 2 - mutation screen and serum levels in patients with anorexia nervosa or obesity and in lean individuals

Identification and functional validation of rare coding variants in genes linked to monogenic obesity

Genetic variants identified in novel candidate genes for anorexia nervosa and analysis of molecular pathways for diagnostic applications

Unexpected identification of obesity-associated mutations in LEP and MC4R genes in patients with anorexia nervosa

Human loss-of-function variants in the serotonin 2C receptor associated with obesity and maladaptive behavior

Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

Identification of Rare Loss-of-Function Genetic Variation Regulating Body Fat Distribution

Protein-truncating variants in BSN are associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease

Fine Mapping of a GWAS-Derived Obesity Candidate Region on Chromosome 16P11.2

Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups

Diagnostic and therapeutic odyssey of two patients with compound heterozygous leptin receptor deficiency

SGCG rs679482 Associates With Weight Loss Success in Response to an Intensively Supervised Outpatient Program

The possible association of two novel heterozygous GNB1 variants with obesity and metabolic disorders

Evaluation of the MC3R gene pertaining to body weight and height regulation and puberty development

Rare Variant Analysis of Obesity-Associated Genes in Young Adults With Severe Obesity From a Consanguineous Population of Pakistan

Identification of a novel leptin receptor (LEPR) variant and proof of functional relevance directing treatment decisions in patients with morbid obesity

7141 Disruption of Transient Receptor Potential Channel 5 Causes Obesity and Maladaptive Behavior

Genetic and epigenetic variations in BDNF gene involved in Anorexia Nervosa

Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations.

Extreme obesity is associated with variation in genes related to the circadian rhythm of food intake and hypothalamic signaling